Details of the Drug
General Information of Drug (ID: DM3R4ZF)
Drug Name |
HI-236
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
HI-236; CHEMBL240416; D-PBT; AC1MHD7C; DDE236; SCHEMBL6246077; BDBM50206060; 1-(5-bromopyridin-2-yl)-3-(2,5-dimethoxyphenethyl)thiourea; 1-(2,5-dimethoxyphenethyl)-3-(5-bromopyridin-2-yl)thiourea; 1-(5-bromo-2-pyridyl)-3-[2-(2,5-dimethoxyphenyl)ethyl]thiourea; N-[2-(2,5-Dimethoxyphenethyl)]-N'-[2-(5-bromopyridyl)]-thiourea; 1-(5-bromopyridin-2-yl)-3-[2-(2,5-dimethoxyphenyl)ethyl]thiourea
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 396.3 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 3.4 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 6 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References